Complete Story
 

04/07/2021

MSHO Featured Corporate Sponsor Assistance Program

TerSera SupportSource

Ter Sera Support Source Logo FinalTerSera is committed to help remove the financial and access barriers that so often get in the way of patients who are prescribed ZOLADEX® (goserelin acetate implant) and VARUBI® (rolapitant) tablets.

To learn more, click here. 

MSHO will profile a different Corporate Sponsor Assistance Program in each Bulletin. To view more Patient Assistance Programs, click here.

Printer-Friendly Version